ReShape Lifesciences Inc. (RSLS)

NASDAQ: RSLS · IEX Real-Time Price · USD

0.171

+0.004 (2.10%)

At close: Apr 23, 2024, 4:00 PM

0.166

-0.005 (-2.64%)

Pre-market: Apr 24, 2024, 8:02 AM EDT

ReShape Lifesciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-11.39	-46.21	-63.15	-21.63	-23.68	-37.38	-34.77	-20.47	-15.55	-9.88
Depreciation & Amortization	0.15	2.15	1.97	1.67	0.89	0.58	0.33	0.19	0.17	0.17
Share-Based Compensation	0.77	2.09	12.23	1.32	2.98	4.69	3.24	0.56	0.21	0.19
Other Operating Activities	-6.49	20.07	33.57	10.09	-3.07	2.67	0.57	0.35	3.79	-0.38
Operating Cash Flow	-16.96	-21.9	-15.38	-8.55	-22.87	-29.43	-30.62	-19.37	-11.39	-9.91
Capital Expenditures	-0.01	-0.09	-0.35	-0.39	-0.19	-1.28	-1.04	-0.35	-0.13	-0.27
Acquisitions	0	0	2.21	-2	0	0	0	0	0	0
Change in Investments	0	0	0	0	2.55	20.8	-20.81	6.55	2.91	-7.65
Investing Cash Flow	-0.01	-0.09	1.86	-2.39	2.36	19.52	-21.86	6.2	2.78	-7.92
Share Issuance / Repurchase	17.57	3.13	46.03	0.68	23.38	9.97	0.43	81.75	0	13.62
Debt Issued / Paid	0	0	-12.73	10.4	-10	-0.03	0	0	5	1.96
Other Financing Activities	-	-	-	-	0	0.05	0.18	1.04	0.06	6.61
Financing Cash Flow	17.57	3.13	33.3	11.08	13.38	9.99	0.61	82.79	5.06	22.19
Exchange Rate Effect	0	0	0.03	-0.11	0	0	0	0	0.01	0.01
Net Cash Flow	0.6	-18.86	19.81	0.02	-7.13	0.08	-51.87	69.62	-3.55	4.38
Free Cash Flow	-16.97	-21.99	-15.73	-8.94	-23.06	-30.71	-31.67	-19.72	-11.53	-10.18
Free Cash Flow Margin	-195.55%	-195.68%	-115.64%	-79.12%	-702.83%	-337.48%	-319.42%	-581.20%	-285.34%	-287.51%
Free Cash Flow Per Share	-2.85	-51.83	-71.97	-114.48	-734.90	-2420.04	-2841.29	-7004.11	-30160.68	-28719.74

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).